This finding is in line with previous studies in which younger age in UC was found to be associated with a more severe disease course and an increased risk of relapses.[22–24] Furthermore, young age is associated with more extended colitis in which escalating therapy towards anti-TNF medication or surgery is frequently required.[25] In contrast, anti-TNF therapy and disease activity were associated with a decrease of healthcare costs. Here, TNF is linked to colitis.